24.04.2018
:
- /. . 10 10 38
16 . . . 1 - -
- . /. 500 10 92
- . /. 250 10 58
. 10 10 26
- . .-. 30 1 189 heel
2 % . 15 81
/. - 1500 20 719 rottapharm
- 2 . . 2 31
2 1,5 97
. /. 200 14 13154 pfizer inc
D3 . / 30 133 beres
- 30 - -
. / 0,25 50 33
- 5 / . 5 15
- /. 3 % . 10 5 201
- /. 400 138
- /. 200 123
. 1 20 100 novartis consu
- /. 1 / . 2 5 113 novartis consu
. /. 30 30 - -
. 10 20 7
- . 2,5 30 121
. 80 60 409 krka
. 80 20 173 krka
. 250 / 200 249 glaxosmithklin
. 400 . 100 613 pharmascience
. 300 . 100 152 pharmascience
. 300 30 179 pharmascience
/. 100 34
. 60 105 glenmark
-6 . 100 , 6 - glenmark -
10 / . 30 132 glenmark
- /. 10000 / . 1 10 3050 pfizer inc
- 2 1 210 , - - -
6 , 41
. /. 4 ., . 1 - -
. 100 . 100 - pharmascience-
. 100 30 131 pharmascience
. /- /. 4000 . 1 - bio sidus -
. /- /. 2000 . 1 379 bio sidus
(B220) DYDUS 250 , . SB2 - berren handlow-
(B221) DYDUS 250 , . SB2 56 berren handlow
(B121) DYDUS 125 , . SB2 - berren handlow-
(B120) DYDUS 125 , . SB2 - berren handlow-
SB2 DYDUS - berren handlow-
SG22 DYDUS - berren handlow-
SB1 DYDUS - berren handlow-
SB3 DYDUS - berren handlow-
20 11
 

0.. - 491 - 492 - 493 - 494 - 495 - 496 - 497 - ..574



, , (c) , , 067-9566747